Dewpoint Therapeutics is a biotech company developing a drug platform that targets biomolecular condensates. Its technology uses machine-learning-based image analysis tools for visualizing condensates and offers an engine for genetically linked condensatopathy, which is a collection of engineered cell lines with trackable condensates to prevent harmful protein sequestration, helping healthcare providers to have access to new therapies to address unmet needs. The company was founded in 2018 and is headquartered in Boston, Massachusetts.

North America

Dresden, Germany

Boston, MA, USA

West Street / River Street, Boston, MA, USA

Dewpoint Therapeutics

Innovation Endeavors invests in visionary founders, transformational technology and emergent ecosystems for a new world.

Innovation Endeavors

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Welcome!

Thank you for joining Innovation Endeavors Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the Innovation Endeavors network as they come up.

You can always update this information later.

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a Innovation Endeavors company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Investing in visionary founders, transformational technology and emergent ecosystems for a new world.